Time to initiation of anti-tuberculosis treatment

Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
J E PirkisA J Plant

Abstract

Fairfield Hospital, Victoria, Australia. To examine delay in initiation of treatment for tuberculosis (TB). Delay in the initiation of treatment for 142 notified TB patients was examined by a retrospective record review. Particular attention was given to the periods between (1) onset of symptoms and initiation of treatment, and (2) determination of sputum positivity and initiation of treatment. An expert panel nominated 30 days and 3 days as 'acceptable' periods for (1) and (2), respectively. Only 31% of patients commenced treatment within 30 days of onset of symptoms. This was so for both sputum smear-positive and negative cases, and was not significantly related to the site of infection, referral source, age, gender or ethnicity of the patient. Of patients with smear-positive pulmonary TB, 86% received treatment within 3 days of this result being demonstrated. Those with a delay of greater than 3 days were all investigated by private doctors through private laboratories. There are appreciable delays in initiation of treatment for TB. Measures to combat these unacceptable delays are discussed.

References

Aug 13, 1992·Nature·B R Bloom
Mar 15, 1992·The New England Journal of Medicine·D E Snider, W L Roper
Sep 11, 1991·Chest·H L RiederD E Snider
Jun 6, 1991·The New England Journal of Medicine·P F BarnesD E Snider
Aug 1, 1994·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·N BeyersP R Donald

❮ Previous
Next ❯

Citations

Aug 25, 1999·Social Science & Medicine·N H LongA Winkvist
Feb 13, 2007·Epidemiology and Infection·C R MacIntyre
Oct 21, 2006·American Journal of Respiratory and Critical Care Medicine·Otto D SchochRobert Thurnheer
Mar 1, 2006·BMC Infectious Diseases·Mohamed Guled FarahGunnar Bjune
Mar 22, 2005·BMC Public Health·Martinho A P S dos SantosLaura C Rodrigues
Jan 16, 2008·BMC Public Health·Dag Gundersen StorlaGunnar Aksel Bjune
Jan 9, 2009·BMC Public Health·Abdi A GeleFekadu Abebe
Jan 1, 2016·Médecine et maladies infectieuses·J Ben AmarH Bouacha
Jan 5, 2011·Tropical Medicine & International Health : TM & IH·Riris Andono AhmadSake J de Vlas
Feb 8, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E OkurG Dabak
Dec 23, 2016·Public Health Reports·Frances TyrrellStephanie Johnston
Sep 26, 2002·BMC Public Health·Meaza DemissieYemane Berhane
May 16, 2018·The American Journal of Tropical Medicine and Hygiene·Shahab E SaqibMartínez-Ruiz Virginia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
T MoriS J Kim
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
E OkurG Dabak
© 2021 Meta ULC. All rights reserved